{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:14:25Z","timestamp":1790633665840,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013227","name":"Health Promotion Administration, Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A1101008"],"award-info":[{"award-number":["A1101008"]}],"id":[{"id":"10.13039\/100013227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jfma.2022.08.012","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T01:01:36Z","timestamp":1662512496000},"page":"2378-2392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Mass screening and eradication of Helicobacter pylori as the policy recommendations for gastric cancer prevention"],"prefix":"10.1016","volume":"121","author":[{"given":"Tsung-Hsien","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-0647","authenticated-orcid":false,"given":"Hsiu-Chi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Lin","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0539-3208","authenticated-orcid":false,"given":"Yi-Ru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsin","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsui-Hsia","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hsiang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2022.08.012_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca Cancer J Clin"},{"key":"10.1016\/j.jfma.2022.08.012_bib2","first-page":"1273","article-title":"Unidentified curved bacilli on gastric epithelium in active chronic gastritis","volume":"1","author":"Warren","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2022.08.012_bib3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2022.08.012_bib4","first-page":"6735e40","article-title":"Human gastric carcinogenesis: a multistep and multifactorial process: first American cancer society award lecture on cancer epidemiology and prevention","volume":"52","author":"Correa","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.jfma.2022.08.012_bib5","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1136\/gutjnl-2014-307595","article-title":"The stomach in health and disease","volume":"64","author":"Hunt","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2022.08.012_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrgastro.2017.53","article-title":"How to stomach an epigenetic insult: the gastric cancer epigenome","volume":"14","author":"Padmanabhan","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2022.08.012_bib7","series-title":"Gastric cancer with special focus on studies from Japan","first-page":"17","article-title":"Gastric cancer worldwide except Japan. In: gastric cancer with special focus on studies from Japan","author":"Tan","year":"2018"},{"key":"10.1016\/j.jfma.2022.08.012_bib8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/j.gastro.2015.01.040","article-title":"Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits","volume":"148","author":"Graham","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2022.08.012_bib9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/gutjnl-2019-320234","article-title":"Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035","volume":"69","author":"Arnold","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2022.08.012_bib10","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jfma.2022.08.012_bib11","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.jfma.2022.08.012_bib12","series-title":"Helicobacter pylori eradication as a strategy for gastric cancer prevention","year":"2014"},{"key":"10.1016\/j.jfma.2022.08.012_bib13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jjco\/hyy077","article-title":"Systematic review group and guideline development group for gastric cancer screening guidelines. Update version of the Japanese guidelines for gastric cancer screening","volume":"48","author":"Hamashima","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jfma.2022.08.012_bib14","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1053\/j.gastro.2017.01.029","article-title":"Effectiveness of the Korean national cancer screening program in reducing gastric cancer mortality","volume":"152","author":"Jun","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2022.08.012_bib15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ijc.27711","article-title":"Global estimates of cancer prevalence for 27 sites in the adult population in 2008","volume":"132","author":"Bray","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jfma.2022.08.012_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12415","article-title":"Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan","volume":"22","author":"Tsuda","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.jfma.2022.08.012_bib17","unstructured":"Choi IJ. Helicobacter pylori eradication for gastric cancer prevention in the general population. ClinicalTrials.gov. Available at: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02112214."},{"key":"10.1016\/j.jfma.2022.08.012_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/gutjnl-2015-309197","article-title":"A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication","volume":"65","author":"Pan","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2022.08.012_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/gutjnl-2021-325630","article-title":"Chinese consensus report on family-based Helicobacter pylori infection control and management (2021 edition)","volume":"71","author":"Ding","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2022.08.012_bib20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/gutjnl-2012-302240","article-title":"The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention","volume":"62","author":"Lee","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2022.08.012_bib21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/gutjnl-2020-322200","article-title":"Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands","volume":"70","author":"Chiang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2022.08.012_bib22","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1053\/j.gastro.2021.01.008","article-title":"Community-based gastric cancer screening coupled with a national colorectal cancer screening program: baseline results","volume":"160","author":"Lee","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2022.08.012_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/jgh.14898","article-title":"Planning mass eradication of Helicobacter pylori infection for indigenous Taiwanese peoples to reduce gastric cancer","volume":"35","author":"Bair","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2022.08.012_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12368","article-title":"Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale","volume":"22","author":"Sheu","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.jfma.2022.08.012_bib25","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2020-322368","article-title":"Asian Pacific Alliance on Helicobacter and Microbiota (APAHAM). Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus","volume":"69","author":"Liou","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2022.08.012_bib26","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jnci\/92.23.1881","article-title":"Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy","volume":"92","author":"Correa","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jfma.2022.08.012_bib27","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/j.gastro.2020.11.017","article-title":"The Colombian chemoprevention trial: 20-year follow-up of a cohort of patients with gastric precancerous lesions","volume":"160","author":"Piazuelo","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2022.08.012_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.291.2.187","article-title":"Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial","volume":"291","author":"Wong","year":"2004","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.jfma.2022.08.012_bib29","first-page":"338","article-title":"Effect of Helicobacter pylori eradication on gastric cancer prevention: updated report from a randomized controlled trial with 26.5 years of follow-up","volume":"S0016\u20135085","author":"Yan","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2022.08.012_bib30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/jnci\/djs003","article-title":"Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality","volume":"104","author":"Ma","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jfma.2022.08.012_bib31","doi-asserted-by":"crossref","first-page":"l5016","DOI":"10.1136\/bmj.l5016","article-title":"Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial","volume":"366","author":"Li","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jfma.2022.08.012_bib32","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2011-300154","article-title":"Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions","volume":"61","author":"Wong","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2022.08.012_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa1909666","article-title":"Family history of gastric cancer and Helicobacter pylori treatment","volume":"382","author":"Choi","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2022.08.012_bib34","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2036.2007.03268.x","article-title":"Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type","volume":"25","author":"Takenaka","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jfma.2022.08.012_bib35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.mcg.0000248006.80699.7f","article-title":"The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer","volume":"42","author":"Ogura","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jfma.2022.08.012_bib36","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.3748\/wjg.15.4290","article-title":"Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?","volume":"15","author":"Mabe","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jfma.2022.08.012_bib37","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/ijc.24591","article-title":"Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels","volume":"125","author":"Yanaoka","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jfma.2022.08.012_bib38","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00535-014-1004-5","article-title":"Seventeen-year effects of eradicating Helicobacter pylori on the prevention of gastric cancer in patients with peptic ulcer; a prospective cohort study","volume":"50","author":"Take","year":"2015","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jfma.2022.08.012_bib39","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.01.028","article-title":"Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2022.08.012_bib40","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","article-title":"Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial","volume":"372","author":"Fukase","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2022.08.012_bib41","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cgh.2013.09.057","article-title":"Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma","volume":"12","author":"Choi","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2022.08.012_bib42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.gie.2018.05.009","article-title":"Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial","volume":"88","author":"Choi","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jfma.2022.08.012_bib43","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa1708423","article-title":"Helicobacter pylori therapy for the prevention of metachronous gastric cancer","volume":"378","author":"Choi","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2022.08.012_bib44","first-page":"639","article-title":"Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer","volume":"6","author":"Uemura","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl 4","key":"10.1016\/j.jfma.2022.08.012_bib45","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2036.2006.00048.x","article-title":"Helicobacter pylori eradication and metachronous gastric cancer after endoscopic mucosal resection of early gastric cancer","volume":"24","author":"Nakagawa","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jfma.2022.08.012_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000173719","article-title":"Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication","volume":"78","author":"Shiotani","year":"2008","journal-title":"Digestion"},{"key":"10.1016\/j.jfma.2022.08.012_bib47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.gie.2011.08.030","article-title":"Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer","volume":"75","author":"Maehata","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jfma.2022.08.012_bib48","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/apt.12633","article-title":"Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients","volume":"39","author":"Kwon","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jfma.2022.08.012_bib49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/ajg.2013.404","article-title":"Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm","volume":"109","author":"Bae","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jfma.2022.08.012_bib50","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/hel.12116","article-title":"The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer","volume":"19","author":"Kim","year":"2014","journal-title":"Helicobacter"},{"key":"10.1016\/j.jfma.2022.08.012_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/jgh.12687","article-title":"Preventing metachronous gastric lesions after endoscopic submucosal dissection through Helicobacter pylori eradication","volume":"30","author":"Jung","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2022.08.012_bib52","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/apt.14263","article-title":"Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection","volume":"46","author":"Kwon","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jfma.2022.08.012_bib53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5009\/gnl17073","article-title":"Long-term effects of Helicobacter pylori eradication on metachronous gastric cancer development","volume":"12","author":"Han","year":"2018","journal-title":"Gut Liver"},{"key":"10.1016\/j.jfma.2022.08.012_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/17474124.2019.1542299","article-title":"The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal","volume":"13","author":"Wu","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2022.08.012_bib55","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1158\/1940-6207.CAPR-08-0170","article-title":"Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinon","volume":"1","author":"Blaser","year":"2008","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.jfma.2022.08.012_bib56","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.aad9358","article-title":"Antibiotic use and its consequences for the normal microbiome","volume":"352","author":"Blaser","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jfma.2022.08.012_bib57","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2468-1253(17)30219-4","article-title":"Asian Pacific Alliance on Helicobacter and Microbiota. Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis","volume":"2","author":"Kuo","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2022.08.012_bib58","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1473-3099(19)30272-5","article-title":"Taiwan Gastrointestinal Disease and Helicobacter Consortium. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial","volume":"19","author":"Liou","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jfma.2022.08.012_bib59","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1136\/gutjnl-2019-319696","article-title":"Effect of Helicobacter pylori on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer","volume":"69","author":"Guo","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2022.08.012_bib60","doi-asserted-by":"crossref","first-page":"E422","DOI":"10.1503\/cmaj.171154","article-title":"Consolidated principles for screening based on a systematic review and consensus process","volume":"190","author":"Dobrow","year":"2018","journal-title":"CMAJ"},{"key":"10.1016\/j.jfma.2022.08.012_bib61","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1146\/annurev-med-042220-020814","article-title":"Diagnosis and treatment of Helicobacter pylori infection","volume":"73","author":"Lee","year":"2022","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jfma.2022.08.012_bib62","unstructured":"The Gastric Cancer Screening and Tracing Subsystem. Internaltional integrated systems, Inc. Health Promotion administration, Ministry of health and Welfare, Taiwan. Available at: https:\/\/pportal.hpa.gov.tw\/Web\/Notice.aspx. Assessed on June 14th, 2022."},{"key":"10.1016\/j.jfma.2022.08.012_bib63","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(96)01501-2","article-title":"Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials","volume":"348","author":"Parsonnet","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2022.08.012_bib64","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/archinte.159.2.142","article-title":"Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer","volume":"159","author":"Fendrick","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jfma.2022.08.012_bib65","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1523-5378.1999.98057.x","article-title":"Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of H. pylori?","volume":"4","author":"Harris","year":"1999","journal-title":"Helicobacter"},{"key":"10.1016\/j.jfma.2022.08.012_bib66","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1365-2036.2002.01204.x","article-title":"The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial","volume":"16","author":"Mason","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jfma.2022.08.012_bib67","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/096914130301000310","article-title":"Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation","volume":"10","author":"Roderick","year":"2003","journal-title":"J Med Screen"},{"key":"10.1016\/j.jfma.2022.08.012_bib68","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1158\/1055-9965.EPI-06-0758","article-title":"Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer","volume":"16","author":"Lee","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jfma.2022.08.012_bib69","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.3748\/wjg.14.3021","article-title":"Cost effectiveness analysis of population-based serology screening and 13C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model","volume":"14","author":"Xie","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jfma.2022.08.012_bib70","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacr.2009.01.022","article-title":"Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada","volume":"6","author":"Xie","year":"2009","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.jfma.2022.08.012_bib71","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.23864","article-title":"Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results","volume":"124","author":"Yeh","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jfma.2022.08.012_bib72","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/hel.12185","article-title":"Helicobacter pylori test-and-treat program can be cost-effective to prevent gastric cancer in Taiwanese adults: referred to the nationwide reimbursement database","volume":"20","author":"Cheng","year":"2015","journal-title":"Helicobacter"},{"key":"10.1016\/j.jfma.2022.08.012_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12563","article-title":"Cost-effectiveness analysis of screen-and-treat strategy in asymptomatic Chinese for preventing Helicobacter pylori-associated diseases","volume":"24","author":"Chen","year":"2019","journal-title":"Helicobacter"},{"key":"10.1016\/j.jfma.2022.08.012_bib74","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s10620-019-05910-1","article-title":"Cost-effectiveness analysis of Helicobacter pylori eradication therapy for prevention of gastric cancer: a Markov model","volume":"65","author":"Han","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jfma.2022.08.012_bib75","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1053\/j.gastro.2021.08.042","article-title":"Testing and treating Helicobacter pylori infection in individuals with family history of gastric cancer is cost-effective","volume":"161","author":"Rustgi","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2022.08.012_bib76","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/PPA.S286860","article-title":"Cost-effectiveness analysis of Helicobacter pylori eradication therapy in first-degree relatives of patients with gastric cancer","volume":"15","author":"Zheng","year":"2021","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jfma.2022.08.012_bib77","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12837","article-title":"Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: a cost-effectiveness analysis","volume":"26","author":"Kowada","year":"2021","journal-title":"Helicobacter"},{"key":"10.1016\/j.jfma.2022.08.012_bib78","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12911","article-title":"Both family-based Helicobacter pylori infection control and management strategy and screen-and-treat strategy are cost-effective for gastric cancer prevention","volume":"27","author":"Ma","year":"2022","journal-title":"Helicobacter"},{"key":"10.1016\/j.jfma.2022.08.012_bib79","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000685","article-title":"Cost-effectiveness modelling of use of urea breath test for the management of Helicobacter pylori-related dyspepsia and peptic ulcer in the UK","volume":"8","author":"Pritchard","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.jfma.2022.08.012_bib80","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12886","article-title":"Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: a cost-effectiveness analysis","volume":"27","author":"Kowada","year":"2022","journal-title":"Helicobacter"},{"key":"10.1016\/j.jfma.2022.08.012_bib81","first-page":"CD01208","article-title":"Non-invasive diagnostic tests for Helicobacter pylori infection","volume":"3","author":"Best","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfma.2022.08.012_bib82","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.3748\/wjg.v19.i45.8188","article-title":"Stool antigen tests for the management of Helicobacter pylori infection","volume":"19","author":"Shimoyama","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jfma.2022.08.012_bib83","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/jgh.15187","article-title":"Risk stratification for gastric cancer after Helicobacter pylori eradication: a population-based study on Matsu Islands","volume":"36","author":"Chiang","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2022.08.012_bib84","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1056\/NEJMcp1710945","article-title":"Helicobacter pylori infection","volume":"380","author":"Crowe","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2022.08.012_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2013.05.028","article-title":"Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence","volume":"12","author":"Graham","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2022.08.012_bib86","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12801","article-title":"Bismuth salts with versus without acid suppression for Helicobacter pylori infection: a transmission electron microscope study","volume":"26","author":"Chiang","year":"2021","journal-title":"Helicobacter"},{"key":"10.1016\/j.jfma.2022.08.012_bib87","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.49.3.347","article-title":"Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts","volume":"49","author":"Helicobacter and Cancer Collaborative Group","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2022.08.012_bib88","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"European Helicobacter and microbiota study group and consensus panel. Management of Helicobacter pylori infection-the Maastricht V\/florence consensus report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2022.08.012_bib89","series-title":"\u201cGastric cancer screening \u2013 who, when, and how?\u201d On the global awareness campaign hosted by the world Gastroenterology organisation","author":"Lee","year":"2019"},{"key":"10.1016\/j.jfma.2022.08.012_bib90","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/1471-2458-13-464","article-title":"Methods to increase participation Working Group. Methods to increase participation in organised screening programs: a systematic review","volume":"13","author":"Camilloni","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jfma.2022.08.012_bib91","first-page":"1","article-title":"Impact of cancer awareness drive on generating awareness of and improving screening for cervical cancer: a study among schoolteachers in India","volume":"4","author":"Shankar","year":"2018","journal-title":"J Glob Oncol"},{"key":"10.1016\/j.jfma.2022.08.012_bib92","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bpg.2015.09.009","article-title":"Assessment of a cancer screening program","volume":"29","author":"Rabeneck","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jfma.2022.08.012_bib93","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/gut.2009.191080","article-title":"Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study","volume":"59","author":"Steevens","year":"2010","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1016\/j.jfma.2022.08.012_bib94","article-title":"Review: epidemiology of Helicobacter pylori infection","volume":"24","author":"Leja","year":"2019","journal-title":"Helicobacter"},{"key":"10.1016\/j.jfma.2022.08.012_bib95","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12483","article-title":"The epidemiology of Helicobacter pylori infection in Europe and the impact of lifestyle on its natural evolution toward stomach cancer after infection: a systematic review","volume":"23","author":"Venneman","year":"2018","journal-title":"Helicobacter"},{"key":"10.1016\/j.jfma.2022.08.012_bib96","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1523-5378.2006.00432.x","article-title":"A community-based study of Helicobacter pylori therapy using the strategy of test, treat, retest, and re-treat initial treatment failures","volume":"11","author":"Lee","year":"2006","journal-title":"Helicobacter"},{"issue":"Suppl 1","key":"10.1016\/j.jfma.2022.08.012_bib97","first-page":"S2e5","article-title":"Multistate and multifactorial progression of gastric cancer: results from community-based mass screening for gastric cancer","volume":"13","author":"Liu","year":"2006","journal-title":"J Med Screen"},{"key":"10.1016\/j.jfma.2022.08.012_bib98","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1136\/gutjnl-2015-310142","article-title":"Taiwan Gastrointestinal Disease and Helicobacter Consortium. Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial","volume":"65","author":"Liou","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2022.08.012_bib99","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ije\/dyy182","article-title":"Effects of screening and universal healthcare on long-term colorectal cancer mortality","volume":"48","author":"Lee","year":"2019","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jfma.2022.08.012_bib100","series-title":"Organizational behavior reading; Leading teams (Core. Curriculum)","author":"Bernstein","year":"2016"},{"key":"10.1016\/j.jfma.2022.08.012_bib101","article-title":"Recent progress in gastric cancer prevention","volume":"50\u201351","author":"Park","year":"2021","journal-title":"Best Pract Res Clin Gastroenterol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664622003229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664622003229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:47:50Z","timestamp":1760539670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664622003229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":101,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0929664622003229"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2022.08.012","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mass screening and eradication of Helicobacter pylori as the policy recommendations for gastric cancer prevention","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2022.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}